Medicare Enrolled

Dr. Gabor Zoltay, MD

Neurology · Gloversville, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
99 E STATE ST, Gloversville, NY 12078
5187735691
Registered in NPPES since 2006
NPI: 1063576205 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Zoltay from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zoltay? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Zoltay

Dr. Gabor Zoltay is a neurology specialist in Gloversville, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Zoltay performed 347 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Zoltay received a total of $9,140 from 46 pharmaceutical and/or device companies across 292 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Zoltay is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ 347 Medicare services $9,140 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
347
Medicare services
Bottom 43% in NY for neurology
Not available
Unique patients (not deduplicated)
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 192 $75 $180
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 130 $51 $161
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
 13 $102 $212
New patient office visit, complex (60-74 min) 12 $162 $320
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,140
Total received (2018-2024)
Avg $1,306/year across 7 years
Top 25% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
292
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,047
2023
$1,319
2022
$1,566
2021
$1,205
2020
$264
2019
$2,899
2018
$840

Payments by company (2024)

UCB, Inc.
$126
LivaNova USA, Inc.
$109
Kyowa Kirin, Inc.
$74
Biogen, Inc.
$70
EMD Serono, Inc.
$60
Lundbeck LLC
$57
Lilly USA, LLC
$57
MITSUBISHI TANABE PHARMA AMERICA, INC.
$54
Neurelis, Inc.
$53
PFIZER INC.
$53
ABBVIE INC.
$51
SK Life Science, Inc.
$37
Eisai Inc.
$33
Genentech USA, Inc.
$33
ARGENX US, INC.
$32
Otsuka America Pharmaceutical, Inc.
$30
JAZZ PHARMACEUTICALS INC.
$29
Bayer Healthcare Pharmaceuticals Inc.
$20
Neurocrine Biosciences, Inc.
$20
Abbott Laboratories
$19
Celgene Corporation
$16
GENZYME CORPORATION
$16
Top 3 companies account for 29.5% of 2024 payments
All-time payments by company (2018-2024) ›
LivaNova USA, Inc.
$2,798
GENZYME CORPORATION
$714
EMD Serono, Inc.
$592
UCB, Inc.
$472
Novartis Pharmaceuticals Corporation
$407
SK Life Science, Inc.
$365
Celgene Corporation
$343
Amgen Inc.
$312
Biogen, Inc.
$252
Neurelis, Inc.
$240
E.R. Squibb & Sons, L.L.C.
$196
Teva Pharmaceuticals USA, Inc.
$178
Genentech USA, Inc.
$176
Neurocrine Biosciences, Inc.
$164
Greenwich Biosciences, Inc.
$157
PFIZER INC.
$147
Lilly USA, LLC
$142
Avanir Pharmaceuticals, Inc.
$99
ABBVIE INC.
$99
Kyowa Kirin, Inc.
$94
Lundbeck LLC
$88
Acorda Therapeutics, Inc
$83
Supernus Pharmaceuticals, Inc.
$77
MITSUBISHI TANABE PHARMA AMERICA, INC.
$76
Boehringer Ingelheim Pharmaceuticals, Inc.
$71
Biohaven Pharmaceuticals, Inc.
$66
JAZZ PHARMACEUTICALS INC.
$65
AbbVie Inc.
$59
Allergan Inc.
$59
Biohaven Pharmaceutical Holding Company Ltd.
$56
ARGENX US, INC.
$52
Eisai Inc.
$51
Mallinckrodt Hospital Products Inc.
$47
Upsher-Smith Laboratories LLC
$47
Otsuka America Pharmaceutical, Inc.
$43
Bayer Healthcare Pharmaceuticals Inc.
$40
Sunovion Pharmaceuticals Inc.
$36
Alexion Pharmaceuticals, Inc.
$34
Janssen Pharmaceuticals, Inc
$28
Adamas Pharmaceuticals, Inc.
$20
MDD US Operations, LLC
$19
Abbott Laboratories
$19
Akcea Therapeutics, Inc.
$16
ACADIA Pharmaceuticals Inc
$16
AbbVie, Inc.
$16
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 44.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPLATZER TALISMAN · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · BOTOX · BOTOX THERAPEUTIC · Briviact · COMIRNATY · EMGALITY · EPIDIOLEX · Epidiolex · GILENYA · GOCOVRI · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · Mirena · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PNEUMOVAX 23 · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · Rebif · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · Soliris · TECFIDERA · TEGSEDI · TROKENDI XR · TYSABRI · UBRELVY · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · XCOPRI · ZEPOSIA · Zinbryta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Gloversville?
Compare neurologists in the Gloversville area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
2
County median income
$62,615
Nearest hospital to ZIP centroid (approximate)
NATHAN LITTAUER HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Zoltay is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Zoltay experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Zoltay performed 192 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Zoltay receive payments from pharmaceutical companies?
Yes. Dr. Zoltay received a total of $9,140 from 46 companies across 292 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zoltay's costs compare to other neurologists in Gloversville?
Dr. Zoltay's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zoltay) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Gloversville
Browse neurologists in Gloversville ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →